Johnson & Johnson is expanding its neurovascular research and development efforts in Galway. This expansion is aimed at addressing specific medical challenges, increasing team capacity, and advancing the development of innovative treatments. The move underscores the company’s commitment to improving healthcare solutions through focused R&D investment.
The American Customer Satisfaction Index read 76.1 in August 2026, the same score it held in 2015, so United States customer expectations have held flat for eleven years while complaints hit records and the variable that actually moved was tolerance.
Read More
TLDR: Regulated-industry marketers who build neuromarketing capabilities at pre-launch stage convert compliance...
Read More